FilingReader Intelligence
Kangtai Biological takes 121m yuan impairment hit
August 21, 2025 at 09:30 AM UTC•By FilingReader AI
Shenzhen Kangtai Biological Products booked total asset impairment provisions of 121.47 million yuan for the first half of 2025, significantly impacting net profit.
The writedowns include 27.38 million yuan for accounts receivable and 93.03 million yuan for inventory impairments.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
2025 semi-annual reportAugust 21, 2025 at 08:00 AM UTC
Special report on the deposit, management, and use of raised funds for the first half of 2025August 21, 2025 at 08:00 AM UTC
Announcement regarding the by-election of a member of the strategy committee and the adjustment of a member of the audit committeeAugust 21, 2025 at 08:00 AM UTC
Announcement of resolutions of the supervisory boardAugust 21, 2025 at 08:00 AM UTC
Announcement of board resolutionsAugust 21, 2025 at 08:00 AM UTC
News Alerts
Get instant email alerts when Shenzhen Kangtai Biological Products publishes news
Free account required • Unsubscribe anytime